Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05150197 · ClinicalTrials.gov registry record · NA

Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease

A NA study of Visual Field Defect, Peripheral, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT05150197 is a NA study of Visual Field Defect, Peripheral that is actively recruiting participants, run by Duke University. The registered enrollment target is 1,000 participants, above the 32-participant average among 6 other Visual Field Defect, Peripheral trials with a reported enrollment target (3025% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05150197, a NA study of Visual Field Defect, Peripheral, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a large instrument the patient must sit at. This new visual field test (called VisuALL) is an FDA-approved virtual reality system which has been used in adults and children. This study will compare the performance of the VisuALL to the standard testing for peripheral vision, which is called the Humphrey Visual Field (HVF) test. The study will recruit both healthy children, as well children and young adults who have eye conditions which require visual field testing as part of their standard care. The test will be performed on a day when the child or young adult already has a scheduled eye appointment as standard care. The test does not touch the eyes or require any eye drops to be given, and there is no known risk associated with the test itself. There may be a risk of loss of confidentiality. Participating in this study will require approximately 30 minutes, has no extra cost associated with it, and will be compensated by a parking pass for the day of the visit. There are no direct benefits for participants. Selected participants will be also be given training and then loaned a home VisuALL system to allow home visual field testing. If your child is selected, additional information would be provided.

Interventions

  • DEVICE VisuALL
  • DEVICE Humphrey Visual Field

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2022-01-19
Est. Completion 2026-02-01
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05150197

The ClinicalTrials.gov registry entry for NCT05150197 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 32-participant average among 6 other Visual Field Defect, Peripheral trials with a reported enrollment target (3025% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Field Defect, Peripheral appearing as the primary indexed condition, and to 2 interventions - of which VisuALL is the first listed.

NCT05150197 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05150197 about?

NCT05150197 is a clinical study titled "Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease". The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a large instrument the patient must sit at. This new visual field test (called VisuALL) is an FDA-approved virtual reality syst...

What is the current status of trial NCT05150197?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-01-19. Estimated completion is 2026-02-01.

What conditions does trial NCT05150197 study?

This clinical trial studies the following conditions: Visual Field Defect, Peripheral.

What interventions are being tested in trial NCT05150197?

The interventions under investigation include: VisuALL (DEVICE), Humphrey Visual Field (DEVICE).

Who is sponsoring clinical trial NCT05150197?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05150197 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Field Defect, Peripheral

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.